Dr. Reddys Laboratories Ltd.

Theranica, an Israeli digital therapeutics company, has entered into a strategic license and supply agreement with Dr. Reddy's Laboratories, for the exclusive marketing and distribution of its FDA-approved Nerivio in India, subject to completion of the regulatory approval process. Nerivio is a wearable migraine treatment that stimulates the body's pain receptors in order to relieve acute and chronic migraine pain.

Under the terms of the agreement, Dr. Reddy's will be responsible for the regulatory approval of Nerivio in India, after which it will exclusively market Nerivio in the country, manufactured and supplied by Theranica.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.